In a new study published in the journal, Maturitas researchers conducted a systematic review and meta-analysis to examine the risk of cardiovascular events in women with and without endometriosis.

The researchers looked at all retrospective and prospective studies that looked at cardiovascular events like cerebrovascular disease, ischemic heart disease, myocardial infarction, and other outcomes related to coronary heart diseases, as well as mortality from cardiovascular events in women with and without endometriosis.

The meta-analysis includes six trials and 254,929 individuals. Three of the studies found that women with endometriosis had a higher risk of ischemic heart disease than women who did not have Endometriosis. Studies demonstrated that endometriosis in premenopausal women was linked to increased arterial stiffness, hypercholesterolemia, and hypertension. The length of oral contraceptive use in women with endometriosis was likewise linked to a higher risk of cardiovascular disease.

Surgical treatments for endometriosis also raised the incidence of stroke and coronary heart disease in women.

Moreover, the use of analgesic drugs to alleviate pelvic pain and the psychological and emotional stress associated with endometriosis are likely to contribute to an elevated risk of cardiovascular events in endometriotic women.

Overall, the findings showed that endometriosis considerably raised women′s risk of cardiovascular disease. Psychological stress and analgesic drugs used to treat persistent pelvic discomfort may potentially raise the risk of cardiovascular disease. Additionally, endometriosis surgical treatment methods increase the risk of stroke and other cardiovascular problems.

(Source: https://www.news-medical.net/news/20230412/Endometriosis-linked-to-increased-risk-of-cardiovascular-disease-in-women.aspx)